A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren GD, Niederau C, Piperno A, Powell LW, Russo MW, Stoelzel U, Stremmel W, Griffel L, Lynch N, Zhang Y, Pietrangelo A.
Phatak P, et al. Among authors: russo mw.
Hepatology. 2010 Nov;52(5):1671-779. doi: 10.1002/hep.23879.
Hepatology. 2010.
PMID: 20814896
Free PMC article.